Volume 8 Issue 99
Published - 14:00 UTC 08:00 EST 9-Apr-2006 
Next Update - 14:00 UTC 08:00 EST 10-Apr-2006

Editor: Susan K. Boyer, RN
© Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.

  

 


Focus on foot care

Researchers have generally believed that teachers are better than parents at evaluating the behavior of school children, because teachers have a bigger group of children for comparison. A University of Virginia study, however, shows that parents are better at assessing their child's emotional states, while teachers are better at rating bad behaviors. The results emphasize the importance of teachers and parents working together in the child's best interest. more  

Congenital rubella syndrome nearly eradicated in the US

Scientists have unexpectedly discovered that mice with the gene defect that causes colon cancer in humans can differ from normal mice in how they respond to radiation treatments. The large intestine carrying the gene defect in mice that received staggered doses of radiation was three to four times more resistant to the radiation than in control mice. more

New research may explain why some who receive growth hormone therapy develop colon polyps

The use of growth hormone therapy has been linked in some people to the development of colon polyps, a possible precursor to colorectal cancer – but medical researchers have debated the extent of a cancer risk. more  

NF-kB as a therapeutic target in malignant gliomas

Researchers from the National Cancer Institute in Bethesda, Md., have found they may be able to successfully treat brain tumor cells with a new targeted therapy that inhibits the activity of a cell protein called nuclear factor-Kappa B (NF-kB). more

PTEN-loss mediated Herceptin (trastuzumab) resistance and targeting the PI3K pathway as a counteracting strategy 

Researchers from The University of Texas M. D. Anderson Cancer Center, Houston, have identified why some women with Her-2 positive breast cancer, an aggressive form of the disease, do not respond to the drug trastuzumab (Herceptin®) or may actually develop a resistance to the treatment. more

A novel, potent and selective IGF-1R small molecule inhibitor blocks activation of IGF-1R signaling in vitro and inhibits IGF-1R dependent tumor growth in vivo  

Researchers from OSI Pharmaceuticals have identified a new small molecule inhibitor that may stop the growth of colon cancer. In this study, investigators discovered and tested an IGF-1R inhibitor, referred to as Compound 1. more

Mutation in blood stem cells provides clues to cancer development

A mutation in blood stem cells occurs in patients with a blood disorder called polycythemia vera (PV), scientists at the Moores Cancer Center at the University of California, San Diego (UCSD) and the Institute for Stem Cell Biology and Regenerative Medicine and Comprehensive Cancer Center at Stanford University School of Medicine have confirmed. more

 

Parents are better at assessing their child's emotional states, while teachers are better at rating bad behaviors.